Target intelligence / Profile preview

Metallo-beta-lactamase domain-containing protein 2 (MBLAC2)

Target
MBLAC2
Molecular classification
Enzyme, Metallo-beta-lactamase family protein, Thioesterase
01

Overview

Metallo-beta-lactamase domain-containing protein 2 (MBLAC2) is a human enzyme that belongs to the metallo-beta-lactamase (MBL) superfamily, sharing a conserved αββα-fold structure and a metal-binding catalytic site, typically coordinating zinc ions. MBLAC2 is a zinc-dependent hydrolase with acyl-CoA thioesterase activity, meaning it hydrolyzes long-chain fatty acyl-CoA substrates, contributing to fatty acid metabolic processes and lipid regulation in the cell. Uniquely, MBLAC2 is S-palmitoylated and found on cellular membranes, interacting with specific acyltransferases such as zDHHC20 and possibly influencing substrate protein palmitoylation—but its exact physiological and disease relevance remains to be fully established. MBLAC2 is detected in the endoplasmic reticulum and plasma membrane and may be functionally linked to the regulation of lipid metabolism. No approved drugs currently target MBLAC2, and no major safety concerns have been linked to inhibition or modulation of this enzyme.

Other names
Acyl-coenzyme A thioesterase MBLAC2Acyl-CoA thioesterase MBLAC2Beta-lactamase MBLAC2Palmitoyl-coenzyme A thioesterase MBLAC2DKFZp686P15118MGC46734
02

Mechanism of action

No drugs target MBLAC2 in clinical use; mechanism would be expected hydrolase inhibition if developed

03

Biological functions

Hydrolysis of long-chain fatty acyl-CoA thioesters (acyl-CoA thioesterase activity)Participates in fatty acid metabolic processMay modulate cellular S-palmitoylation through interaction with acyltransferases like zDHHC20
04

Disease associations

Other (potential association with metabolic regulation)Jalili Syndrome (gene associations)Usher Syndrome, Type Iic (gene associations)No strong evidence for direct roles in major disease classes such as cancer, inflammation, neurodegenerative disease, or cardiovascular disease

Beyond the preview

Go deeper on Metallo-beta-lactamase domain-containing protein 2 (MBLAC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metallo-beta-lactamase domain-containing protein 2 (MBLAC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call